mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.49 |
0.0003 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0005 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |